ArticleFrontiers in oncology2021

The Efficacy and Safety of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Thymosin in Advanced Non-Small Cell Lung Cancer Patients Harboring Active Epidermal Growth Factor Receptor Mutations.

Yongdong Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.